Singapore: Difficult to derail 2010 growth momentum

Macquarie Research says with increases in pharmaceutical output capacity and the strong momentum in the service sector that could cushion the fall-out, contraction previously forecast may not come to pass.

“Favourable base effects have been pointed to as a key cause for the startling strength of Singapore’s economic recovery, especially in the wake of the 18.8% YoY GDP growth in 2Q10. Such views have been further aided by the revision of the base year for GDP figures, however, this overlooks the surge in pharmaceutical output and exports in 1H10,” said Macquarie Research.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia